Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.


CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.


CERIMED offers its 100 seats conference room and many meeting rooms to organize your own events, for administrative, educational and training purposes (seminars, workshops, curses). Feel free to request a quote.

Dernières Publications (10/132)

  1. Cammilleri, S, Gabriel, S, Le Troter, A, Chagnaud, C, Mattei, JP, Bendahan, D et al.. Knee psoriatic enthesitis assessed using Positron Emission Tomography (PET)- FNa merged to ultrahigh field magnetic resonance imaging (UHF-MRI). Joint Bone Spine. 2019; :. doi: 10.1016/j.jbspin.2019.01.002. PubMed PMID:30660806 .
  2. Magalon, J, Velier, M, Simoncini, S, François, P, Bertrand, B, Daumas, A et al.. Molecular profile and proangiogenic activity of the adipose-derived stromal vascular fraction used as an autologous innovative medicinal product in patients with systemic sclerosis. Ann. Rheum. Dis. 2019; :. doi: 10.1136/annrheumdis-2018-214218. PubMed PMID:30612118 .
  3. Gach, P, Tuchtan-Torrents, L, Delteil, C, Adalian, P, Piercecchi, MD, Ebert, LC et al.. Virtual reconstruction of paranasal sinuses from CT data: A feasibility study for forensic application. Diagn Interv Imaging. 2018; :. doi: 10.1016/j.diii.2018.11.011. PubMed PMID:30553743 .
  4. Guedj, E, Graillon, T, Chinot, O, Taieb, D. Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging. 2018; :. doi: 10.1007/s00259-018-4221-y. PubMed PMID:30552446 .
  5. Colard, E, Delcourt, S, Padovani, L, Thureau, S, Dumouchel, A, Gouel, P et al.. A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurement. EJNMMI Res. 2018;8 (1):99. doi: 10.1186/s13550-018-0454-9. PubMed PMID:30443801 PubMed Central PMC6238015.
  6. Moyon, A, Garrigue, P, Balasse, L, Fernandez, S, Brige, P, Nollet, M et al.. Early prediction of revascularisation by angiomotin-targeting positron emission tomography. Theranostics. 2018;8 (18):4985-4994. doi: 10.7150/thno.27728. PubMed PMID:30429881 PubMed Central PMC6217063.
  7. Leenhardt, L, Leboulleux, S, Bournaud, C, Zerdoud, S, Schvartz, C, Ciappuccini, R et al.. Recombinant thyrotropin vs levothyroxine withdrawal in 131I therapy of N1 thyroid cancer: a large matched cohort study (ThyrNod). J. Clin. Endocrinol. Metab. 2018; :. doi: 10.1210/jc.2018-01589. PubMed PMID:30398518 .
  8. Garrigue, P, Tang, J, Ding, L, Bouhlel, A, Tintaru, A, Laurini, E et al.. Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proc. Natl. Acad. Sci. U.S.A. 2018;115 (45):11454-11459. doi: 10.1073/pnas.1812938115. PubMed PMID:30348798 PubMed Central PMC6233080.
  9. Verger, A, Malbos, E, Reynaud, E, Mallet, P, Mestre, D, Pergandi, JM et al.. Brain metabolism and related connectivity in patients with acrophobia treated by virtual reality therapy: an 18F-FDG PET pilot study sensitized by virtual exposure. EJNMMI Res. 2018;8 (1):93. doi: 10.1186/s13550-018-0446-9. PubMed PMID:30276498 PubMed Central PMC6167271.
  10. Verger, A, Guedj, E. The renaissance of functional 18F-FDG PET brain activation imaging. Eur. J. Nucl. Med. Mol. Imaging. 2018;45 (13):2338-2341. doi: 10.1007/s00259-018-4165-2. PubMed PMID:30269156 .
Search PubMed